Finance

Beta
Ask
Lists
603739:SHA
Qingdao Vland Biotech INC
CN¥12.52
-0.40%
(-0.050) 1D
Jun 15, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603739...
Open
CN¥12.57
High
CN¥12.82
Low
CN¥12.37
Mkt. cap
3.18B
Avg. vol.
4.26M
Volume
3.03M
Dividend
0.80%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 29, 2026
P/E ratio
41.02
52-wk high
CN¥18.41
52-wk low
CN¥12.20
EPS
CN¥0.31
No. of employees
2K
Open
CN¥12.57
High
CN¥12.82
Low
CN¥12.37
Mkt. cap
3.18B
Avg. vol.
4.26M
Volume
3.03M
Dividend
0.80%
Quarterly dividend
CN¥0.02
Ex-dividend date
May 29, 2026
P/E ratio
41.02
52-wk high
CN¥18.41
52-wk low
CN¥12.20
EPS
CN¥0.31
No. of employees
2K
News stories
From sources across the web
About Qingdao Vland Biotech INC
CEO-
Employees1.52K
FoundedFeb 23, 2005
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
342.00M
363.60M
350.33M
345.05M
Cost of goods sold
184.78M
206.93M
196.37M
192.44M
Cost of revenue
184.78M
206.93M
196.37M
192.44M
Research and development expenses
35.39M
36.36M
38.97M
30.17M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
88.80M
84.53M
94.78M
87.70M
Operating expense
132.09M
110.42M
161.80M
124.11M
Total operating expenses
316.87M
317.34M
358.18M
316.55M
Operating income
25.13M
46.26M
-7.84M
28.50M
Other non operating income
-1.34M
439.18K
-226.95K
584.70K
EBT including unusual items
28.70M
55.31M
15.32M
32.23M
EBT excluding unusual items
18.14M
42.98M
-14.43M
26.98M
Income tax expense
5.48M
12.18M
786.41K
6.78M
Effective tax rate
19.11%
22.03%
5.13%
21.03%
Other operating expenses
3.37M
-16.77M
24.95M
4.07M
Net income
17.14M
35.06M
8.03M
17.87M
Net profit margin
5.01%
9.64%
2.29%
5.18%
Earnings per share
-
-
-
-
Interest and investment income
-
161.61K
177.29K
3.32M
Interest expense
-5.69M
-3.83M
-5.59M
-5.42M
Net interest expenses
-5.69M
-3.67M
-5.41M
-2.11M
Depreciation and amortization charges
-
-
-
-
EBITDA
52.39M
73.86M
21.14M
57.49M
Gain or loss from assets sale
-393.28K
393.28K
-470.74K
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more